
HCA Healthcare
(NYSE) HCA
| Metric | Price | Date |
|---|---|---|
| Last close | USD 385.74 | 2026-07-16 |
| Period | Price return | Price at period start | Period start date |
|---|---|---|---|
| 1 week | -5.69% | USD 409.01 | 2026-07-09 |
| 1 month | -2.82% | USD 396.93 | 2026-06-16 |
| 3 month | -20.8% | USD 487.02 | 2026-04-17 |
| Year to date | -17.09% | USD 465.23 | 2025-12-31 |
| 1 year | +7.11% | USD 360.14 | 2025-07-16 |
| 3 year | +35.28% | USD 285.13 | 2023-07-17 |
| 5 year | +83.51% | USD 210.20 | 2021-07-16 |
| Since inception | +1,571.39% | USD 23.08 | 2011-03-10 |
HCA Healthcare Financials at a Glance
Market Cap
Revenue (TTM)
Net Income (TTM)
EPS (TTM)
P/E Ratio
Dividend
Beta (Volatility)
Dividend
Beta (Volatility)
Price
Volume
Open
Price
Volume
Open
Previous Close
Daily Range
52-Week Range
Estimated Earnings Date
Dividend
Beta (Volatility)
Price
Volume
Open
Previous Close
Daily Range
52-Week Range
Estimated Earnings Date
HCA News


What Is the Fortune 100?
HCA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout HCA Healthcare
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
320,000
CEO
Samuel N. Hazen, MBA
Website
www.hcahealthcare.comHeadquarters
Nashville, TN 37203, US
HCA Financials
Key Financial Metrics (TTM)
Gross Margin
Operating Margin
Net Income Margin
Return on Equity
Return on Capital
Return on Assets
Earnings Yield
Dividend Yield
Payout Ratio
Stock Overview
Market Cap
Shares Outstanding
Volume
Avg. Volume
Financials (TTM)
Gross Profit
Operating Income
EBITDA
Operating Cash Flow
Capital Expenditure
Free Cash Flow
Cash & ST Invst.
Total Debt
HCA Healthcare Performance Analysis
| Fiscal year | Period end | Revenue | YoY growth |
|---|---|---|---|
| 2022 | 2022-12-31 | USD 60,233,000,000 | 2.5% |
| 2023 | 2023-12-31 | USD 64,968,000,000 | 7.9% |
| 2024 | 2024-12-31 | USD 70,603,000,000 | 8.7% |
| 2025 | 2025-12-31 | USD 75,600,000,000 | 7.1% |
| Fiscal quarter | Period end | QoQ growth |
|---|---|---|
| Q2 | 2025-06-30 | 1.6% |
| Q3 | 2025-09-30 | 3.0% |
| Q4 | 2025-12-31 | 1.8% |
| Q1 | 2026-03-31 | -2.1% |
| Fiscal year | Period end | Diluted EPS | YoY growth |
|---|---|---|---|
| 2022 | 2022-12-31 | USD 19.15 | -9.5% |
| 2023 | 2023-12-31 | USD 18.96 | -1.0% |
| 2024 | 2024-12-31 | USD 22.00 | 16.0% |
| 2025 | 2025-12-31 | USD 28.33 | 28.8% |
| Fiscal quarter | Period end | QoQ growth |
|---|---|---|
| Q2 | 2025-06-30 | 5.9% |
| Q3 | 2025-09-30 | 1.9% |
| Q4 | 2025-12-31 | 17.0% |
| Q1 | 2026-03-31 | -12.2% |
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
+4.3%
Gross Profit
-62.1%
Gross Margin
N/A
Market Cap
N/A
Market Cap/Employee
N/A
Employees
N/A
Net Income
+0.6%
EBITDA
+1.8%
Quarterly Fundamentals
Total Cash
-11.3%
Total Debt
+7.3%
Accounts Receivable
+2.1%
Inventory
-6.3%
Long Term Debt
-3.7%
Short Term Debt
+142.5%
Return on Assets
N/A
Return on Invested Capital
N/A
Free Cash Flow
+35.6%
Operating Cash Flow
+22.0%





